Medicines Australia has backed concerns over the decision-making process for MSD's ZINPLAVA while the FDA advised against the current use of the intervention the PBAC used as the significant basis for the rejection. …
Latest Video
New Stories
-
Access delayed - the stakes are high for the industry's next agreements
October 27, 2026 - - Latest News -
Services Australia annual report confirms decline in prescription volume
October 27, 2026 - - Latest News -
CSL announces new chair as Brian McNamee prepares to bow out
October 26, 2026 - - Latest News -
There is an urgent need to reconsider the question of PBS sustainability
October 26, 2026 - - Latest News -
PBS share of health spending on track to halve as Canberra prepares to negotiate with industry
October 26, 2026 - - Latest News -
Documents reveal net PBS spending set to remain on life support to the end of decade
October 26, 2026 - - Latest News -
Health's multi-million dollar rebuild of cost-recovery fees is happening out of view
October 26, 2026 - - Latest News